{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:49:48Z","timestamp":1767134988430,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009769","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000}}],"reference-count":83,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009769.pub2","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T19:05:45Z","timestamp":1381259145000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Beclometasone for chronic obstructive pulmonary disease"],"prefix":"10.1002","volume":"2013","author":[{"given":"Daan A","family":"De Coster","sequence":"first","affiliation":[{"name":"University College London, Upper 3rd Floor, UCL Medical School (Royal Free Campus); Department of Primary Care and Population Health; Rowland Hill Street London UK NW3 2PF"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvyn","family":"Jones","sequence":"additional","affiliation":[{"name":"UCL; Department of Primary Care and Population Health, Division of Population Health, Faculty of Population Health Sciences; Royal Free Campus Rowland Hill Street London UK NW3 2PF"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita","family":"Thakrar","sequence":"additional","affiliation":[{"name":"UCL; Department of Primary Care and Population Health; Upper 3rd Floor, UCL Medical School (Royal Free Campus) London UK NW3 2PF"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,10,9]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD009769.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.rmed.2010.09.008","article-title":"Beclomethasone\/formoterol in the management of COPD: a randomised controlled trial","volume":"104","author":"Calverley","year":"2010","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0002|cit2","first-page":"A463","article-title":"Effects of high dose inhaled beclomethasone in the rate of decline in FEV1 in patients with chronic obstructive pulmonary disease: results of a 2 years prospective multicentre study","volume":"151","author":"Derenne","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0003|cit3","article-title":"Chapter 8: Beneficial clinical effects of a two-year treatment with inhaled beclomethasone dipropionate 1500 \u00b5g daily in moderate to severe chronic obstructive pulmonary disease\u2014a multicenter randomized placebo-controlled trial","volume-title":"Asthma and Chronic Obstructive Pulmonary Disease (COPD)\u2014Aspects of Treatment With Inhaled Corticosteroids of Patients With Mild Signs or a Clinical Diagnosis [Dissertation]","author":"Grunsven","year":"1999"},{"issue":"Suppl. 2","key":"10.1002\/14651858.CD009769.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1365-2222.1999.00021.x","article-title":"A double-blind placebo-controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease","volume":"29","author":"Weir","year":"1999","journal-title":"Clinical and Experimental Allergy"},{"issue":"1053","key":"10.1002\/14651858.CD009769.pub2-BIB0005|cit5","first-page":"370","article-title":"The efficacy of inhaled corticosteroids in the management of non asthmatic chronic airflow obstruction","volume":"110","author":"Boothman-Burrell","year":"October 1997","journal-title":"New Zealand Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD009769.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1053\/meta.2001.27231","article-title":"Decreased osteocalcin levels in patients with chronic obstructive pulmonary disease using long-term inhaled beclomethasone dipropionate","volume":"50","author":"Dinc","year":"2001","journal-title":"Metabolism: Clinical and Experimental"},{"issue":"11","key":"10.1002\/14651858.CD009769.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.rmed.2005.03.034","article-title":"Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease","volume":"99","author":"John","year":"2005","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0008|cit8","unstructured":"John M Bosse S Schumacher A Oltmanns U Witt C Effect of inhaled beclomethasone HFA 134 (QVAR\/Ventolair) on health related quality of life in patients with chronic obstructive pulmonary disease [Abstract] American Thoracic Society International Conference; 2005 May 20-25; San Diego [A43] [Poster: F43]"},{"issue":"4","key":"10.1002\/14651858.CD009769.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/A:1015520110663","article-title":"Treatment and quality of life in patients with chronic obstructive pulmonary disease","volume":"11","author":"Miravitlles","year":"2002","journal-title":"Quality of Life Research"},{"issue":"8","key":"10.1002\/14651858.CD009769.pub2-BIB0010|cit10","first-page":"497","article-title":"Clinical study of inhaled corticosteroid in non-asthmatic chronic obstructive pulmonary disease","volume":"21","author":"Ouyang","year":"1998","journal-title":"Chung-Hua Chieh Ho Ho Hu Hsi Tsa Chih"},{"issue":"3","key":"10.1002\/14651858.CD009769.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00044011-200626030-00005","article-title":"Comparison of fenspiride with beclomethasone as adjunctive anti-inflammatory treatment in patients with chronic obstructive pulmonary disease","volume":"26","author":"Shmelev","year":"2006","journal-title":"Clinical Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD009769.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0300-2977(96)00081-2","article-title":"The effects of inhaled glucocorticoids on bone mass and biochemical markers of bone homeostasis: a 1-year study of beclomethasone versus budesonide","volume":"50","author":"Struijs","year":"1997","journal-title":"Netherlands Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009769.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1164\/ajrccm\/146.2.389","article-title":"Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation","volume":"146","author":"Thompson","year":"1992","journal-title":"American Review of Respiratory Disease"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2147\/COPD.S23746","article-title":"Effects of beclomethasone\/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients","volume":"6","author":"Tzani","year":"2011","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0015|cit15","unstructured":"Tzani P Crisafulli E Nicolini G Clini E Aiello M Chetta A Reduction in air trapping and dyspnea with an extrafine combination of beclomethasone and formoterol in COPD [Abstract] European Respiratory Society 20th Annual Congress; 2010 September 18-22; Barcelona"},{"issue":"5","key":"10.1002\/14651858.CD009769.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1378\/chest.107.5.1199","article-title":"The influence of an inhaled steroid on quality of life in patients with asthma or COPD","volume":"107","author":"Schayck","year":"1995","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD009769.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/thx.45.2.112","article-title":"Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate","volume":"45","author":"Weir","year":"1990","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD009769.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/thx.48.4.309","article-title":"Effects of high dose inhaled beclomethasone dipropionate 750 \u03bcg and 1500 \u03bcg twice daily and 40 mg oral prednisolone on lung function, symptoms and bronchial hyperresponsiveness in patients with non-asthmatic airflow obstruction","volume":"48","author":"Weir","year":"1993","journal-title":"Thorax"},{"issue":"Suppl 28","key":"10.1002\/14651858.CD009769.pub2-BIB0019|cit19","first-page":"413S","article-title":"Effectiveness of long-term treatment with inhaled corticosteroids in metal workers with COPD","volume":"12","author":"Vengerov","year":"1998","journal-title":"European Respiratory Journal Supplement"},{"issue":"1","key":"10.1002\/14651858.CD009769.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1183\/09031936.00207611","article-title":"A trial of beclomethasone\/formoterol in COPD using EXACT-PRO to measure exacerbations","volume":"41","author":"Singh","year":"2013","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0021|cit21","unstructured":"Wedzicha WA BDP\/FF versus formoterol fumarate (FF) in patients with severe COPD (lung function and exacerbation rate) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00929851"},{"issue":"4","key":"10.1002\/14651858.CD009769.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002310.pub4","article-title":"Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children","author":"Adams","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009769.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1378\/chest.09-1305","article-title":"Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and metaregression of randomized controlled trials","volume":"137","author":"Agarwal","year":"2010","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD009769.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/dtb.2010.05.0037","article-title":"Preventing exacerbations in COPD","volume":"48","author":"Anon","year":"2010","journal-title":"Drug and Therapeutics Bulletin"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1164\/ajrccm\/136.1.225","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma","volume":"136","author":"American Thoracic Society","year":"1987","journal-title":"American Review of Respiratory Disease"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0026|cit26","volume-title":"Standards for the Diagnosis and Management of Patients With COPD","author":"American Thoracic Society\/European Respiratory Society Task Force","year":"2004"},{"issue":"20","key":"10.1002\/14651858.CD009769.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2008.717","article-title":"Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"300","author":"Bradley-Drummond","year":"2008","journal-title":"JAMA"},{"issue":"Suppl C","key":"10.1002\/14651858.CD009769.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0954-6111(03)80027-6","article-title":"The burden of COPD in the U.K.: results from the confronting COPD survey","volume":"97","author":"Britton","year":"2003","journal-title":"Respiratory Medicine"},{"issue":"26","key":"10.1002\/14651858.CD009769.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta5260","article-title":"Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature","volume":"5","author":"Brocklebank","year":"2001","journal-title":"Health Technology Assessment"},{"issue":"7318","key":"10.1002\/14651858.CD009769.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/bmj.323.7318.896","article-title":"Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma","volume":"323","author":"Brocklebank","year":"2001","journal-title":"British Medical Journal"},{"issue":"5800","key":"10.1002\/14651858.CD009769.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/bmj.1.5800.585","article-title":"Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma","volume":"1","author":"Brown","year":"1972","journal-title":"British Medical Journal"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD009769.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/thx.52.2008.S1.5","article-title":"BTS guidelines for the management of chronic obstructive pulmonary disease","volume":"52","author":"British Thoracic Society Standards of Care Committee","year":"1997","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jclinepi.2005.11.010","article-title":"Single data extraction generated more errors than double data extraction in systematic reviews","volume":"59","author":"Buscemi","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0034|cit34","unstructured":"Cochrane Airways Group Developing a search strategy for an Airways Group systematic review http:\/\/airways.cochrane.org\/authors"},{"issue":"2","key":"10.1002\/14651858.CD009769.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"European Respiratory Journal"},{"issue":"10","key":"10.1002\/14651858.CD009769.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009769.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/thx.52.1.55","article-title":"Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients","volume":"52","author":"Clark","year":"1997","journal-title":"Thorax"},{"issue":"1","key":"10.1002\/14651858.CD009769.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1378\/chest.127.1.335","article-title":"Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians\/American College of Asthma, Allergy, and Immunology","volume":"127","author":"Dolovich","year":"2005","journal-title":"Chest"},{"issue":"8","key":"10.1002\/14651858.CD009769.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/thx.48.8.817","article-title":"Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year","volume":"48","author":"Fabbri","year":"1993","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0040|cit40","first-page":"1","article-title":"American emphysema and British bronchitis: a standardized comparative study","volume":"90","author":"Fletcher","year":"1964","journal-title":"American Review of Respiratory Disease"},{"issue":"3","key":"10.1002\/14651858.CD009769.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1370\/afm.517","article-title":"Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes","volume":"4","author":"Gartlehner","year":"2006","journal-title":"Annals of Family Medicine"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0042|cit42","unstructured":"Gold Science Committee Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010 http:\/\/www.goldcopd.org\/"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0043|cit43","unstructured":"Gold Science Committee Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013 http:\/\/www.goldcopd.org\/"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/thx.42.10.773","article-title":"A measure of quality of life for clinical trials in chronic lung disease","volume":"42","author":"Guyatt","year":"1987","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0045|cit45","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JAA.S25415","article-title":"Extrafine inhaled corticosteroid therapy in the control of asthma","volume":"6","author":"Ivancs\u00f3","year":"2013","journal-title":"Journal of Asthma and Allergy"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD009769.pub2-BIB0047|cit47","first-page":"25","article-title":"Chronic obstructive lung disease: corticosteroids","volume":"39","author":"Izquierdo","year":"2003","journal-title":"Archivos de Bronconeumologia"},{"issue":"1","key":"10.1002\/14651858.CD009769.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003537","article-title":"Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease","author":"Jones","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009769.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1345\/aph.1L546","article-title":"Comparison of inhaled corticosteroids: an update","volume":"43","author":"Kelly","year":"2009","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0050|cit50","first-page":"75","article-title":"Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: a real world observational study","volume":"2","author":"Kemp","year":"2010","journal-title":"ClinicoEconomics and Outcomes Research"},{"issue":"Suppl B","key":"10.1002\/14651858.CD009769.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0954-6111(00)80144-4","article-title":"From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs","volume":"94","author":"Kunka","year":"2000","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1346\u201353","DOI":"10.1183\/09031936.98.12061346","article-title":"Improved airway targeting with the CFC-free HFA\u2013beclomethasone metered-dose inhaler compared with CFC\u2013beclomethasone","volume":"12","author":"Leach","year":"1998","journal-title":"European Respiratory Journal"},{"issue":"9","key":"10.1002\/14651858.CD009769.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009769.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1183\/09031936.00095909","article-title":"Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD","volume":"35","author":"Loke","year":"2010","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD009769.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1007\/s11095-012-0691-y","article-title":"Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways","volume":"29","author":"Longest","year":"2012","journal-title":"Pharmaceutical Research"},{"issue":"2","key":"10.1002\/14651858.CD009769.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/fampra\/cmn006","article-title":"Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients: an exploratory study","volume":"25","author":"Lucas","year":"2008","journal-title":"Family Practice"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.93.3.580","article-title":"Evaluation of clinical methods for rating dyspnea","volume":"93","author":"Mahler","year":"1988","journal-title":"Chest"},{"issue":"10","key":"10.1002\/14651858.CD009769.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.2105013","article-title":"Systemic effect comparisons of six inhaled corticosteroid preparations","volume":"165","author":"Martin","year":"2002","journal-title":"American Journal of Respiratory Care Medicine"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0059|cit59","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA) CLENIL \u00ae MODULITE \u00ae 50 micrograms peractuation pressurised inhalation solution (beclometasone dipropionate) PL 08829\/0133 Public Assessment Report www.mhra.gov.uk\/home\/groups\/l-unit1\/documents\/...\/con014210.pdf\u200e"},{"issue":"2","key":"10.1002\/14651858.CD009769.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD009769.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009769.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003794.pub3","article-title":"Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease","author":"Nannini","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD009769.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006829.pub2","article-title":"Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonists for chronic obstructive pulmonary disease","author":"Nannini","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0064|cit64","unstructured":"National Collaborating Centre for Acute and Chronic Conditions Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care, 2010 http:\/\/www.nice.org.uk\/guidance\/CG101"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0065|cit65","unstructured":"National Prescribing Centre COPD: data focused commentary http:\/\/www.npc.nhs.uk\/therapeutics\/respiratory\/copd\/data.php"},{"issue":"4","key":"10.1002\/14651858.CD009769.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1183\/09031936.00095906","article-title":"Beclomethasone\/formoterol versus budesonide\/formoterol combination therapy in asthma","volume":"29","author":"Papi","year":"2007","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/JAA.S17709","article-title":"Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD","volume":"4","author":"Price","year":"2011","journal-title":"Journal of Asthma and Allergy"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD009769.pub2-BIB0068|cit68","first-page":"7","article-title":"Standardized lung function testing","volume":"19","author":"Quanjer","year":"1983","journal-title":"Bulletin Europeen de Physiopathologie Respiratoire"},{"issue":"4","key":"10.1002\/14651858.CD009769.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003902","article-title":"Oral theophylline for chronic obstructive pulmonary disease","author":"Ram","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0070|cit70","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"3","key":"10.1002\/14651858.CD009769.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00198-003-1398-z","article-title":"Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review","volume":"14","author":"Richy","year":"2003","journal-title":"Osteoporosis International"},{"issue":"4","key":"10.1002\/14651858.CD009769.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1378\/chest.09-0821","article-title":"Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review","volume":"136","author":"Rodrigo","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD009769.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1753465809103737","article-title":"Use of dry powder inhalers in acute exacerbations of asthma and COPD","volume":"3","author":"Selroos","year":"2009","journal-title":"Therapeutic Advances in Respiratory Disease"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1016\/S0140-6736(09)61250-2","article-title":"Budesonide and the risk of pneumonia: a meta-analysis of individual patient data","volume":"374","author":"Sin","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD009769.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007033.pub3","article-title":"Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease","author":"Spencer","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009769.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1183\/09031936.00190908","article-title":"Inhaled corticosteroids in COPD: the case against","volume":"34","author":"Suissa","year":"2009","journal-title":"European Respiratory Journal"},{"issue":"8","key":"10.1002\/14651858.CD009769.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009769.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/thx.54.1.7","article-title":"Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis","volume":"54","author":"Grunsven","year":"1999","journal-title":"Thorax"},{"issue":"5","key":"10.1002\/14651858.CD009769.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1378\/chest.115.5.1278","article-title":"Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers","volume":"115","author":"Wales","year":"1999","journal-title":"Chest"},{"issue":"5","key":"10.1002\/14651858.CD009769.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007891.pub2","article-title":"Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease","author":"Welsh","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009769.pub2-BIB0081|cit81","volume-title":"The Global Burden of Disease: 2004 Update","author":"World Health Organization","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD009769.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002991.pub2","article-title":"Inhaled corticosteroids for stable chronic obstructive pulmonary disease","author":"Yang","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009769.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002991.pub3","article-title":"Inhaled corticosteroids for stable chronic obstructive pulmonary disease","author":"Yang","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009769.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T12:06:31Z","timestamp":1725451591000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009769.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,9]]},"references-count":83,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009769.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,9]]}}}